Literature DB >> 17239571

The impact of large tidal volume ventilation on the absorption of inhaled insulin in rabbits.

Astrid H Petersen1, Torben Laursen, Bo Ahrén, Thomas R Pieber, Per Clauson, Per Wollmer.   

Abstract

Previous studies have shown that ventilation patterns affect absorption of inhaled compounds. Thus, the aim of this study was to investigate the effect of large tidal volume ventilation (LTVV) on the absorption of inhaled insulin in rabbits. Mechanically ventilated rabbits were given human insulin via a nebuliser system, and plasma insulin was measured for the following 120min. Ventilation was adjusted to (1) normal tidal volume ventilation (NTVV) for the entire period after dosing (NTVV group), to (2) LTVV for the entire period after dosing (LTVV group), to (3) NTVV except for 15min LTVV immediately after dosing (Early LTVV group), or to (4) NTVV except for 15min LTVV starting at 60min after dosing (late LTVV group). Insulin absorption (AUC(ins(0-120min))) was increased by 149% for the LTVV group compared to NTVV group (p<0.01) with increased maximal insulin concentration (106%, p=0.03). The Early LTVV group showed a changed absorption profile. For the late LTVV group an increase in insulin levels was observed after the LTVV period (not significant compared to the NTVV group). These data could potentially have implications for patients using inhaled insulin in situations where a change in breathing pattern is seen, such as exercise.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17239571     DOI: 10.1016/j.ejps.2006.12.002

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  1 in total

1.  The effect of exercise on the absorption of inhaled human insulin in healthy volunteers.

Authors:  Astrid H Petersen; Gerd Köhler; Stefan Korsatko; Andrea Wutte; Manfred Wonisch; Agnes Mautner; Birgitte B Rønn; Per Clauson; Torben Laursen; Per Wollmer; Thomas R Pieber
Journal:  Br J Clin Pharmacol       Date:  2007-08-31       Impact factor: 4.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.